Webinar: Advanced brain metastases management: what a LCNS needs to know | Lung Cancer Nursing UK Skip to main content

Webinar: Advanced brain metastases management: what a LCNS needs to know

Friday 27th November 2020, 13:00 - 14:00

The management of brain metastases in advanced stage 4 lung cancer is complex. Dr McBain is a world leading expert in the management and treatment options for brain metastases. Dr McBain is a Consultant Clinical Oncologist at The Christie NHS FT, Manchester. Dr McBain sub-specialises in Neuro-oncology, and manages patients with both primary and secondary brain tumours. With life expectancy increasing due to better management of brain metastases and treatments sometimes controlling brain metastases for longer, Dr McBain has agreed to present her knowledge and experience on this subject for an exclusive LCNUK webinar. Dr. McBain presented last year at our 20th anniversary LCNUK conference and is back to cover this subject in more detail, in our virtual session by popular demand

Watch On Demand

Speakers

Catherine McBainCatherine McBain

Consultant Clinical Oncologist at The Christie NHS FT, Manchester.

Thank you to our webinar organiser Takeda Oncology

 

A red and white logo</p>
<p>Description automatically generated with medium confidenceAt Takeda Oncology, we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients.

This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the resources of a global pharmaceutical company, we are finding innovating ways to improve the treatment of cancer.

We’ve built a portfolio of paradigm changing therapies and a leading oncology pipeline. Though we’ve made great strides in our fight against cancer, we are determined to do more – to work harder and to reach higher. We continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the innovators in oncology that we are today.

We know that our mission is not a quick or simple one, but we are up for the task: we aspire to cure cancer.

https://www.takeda.com/en-gb/

 

  • The views expressed by speakers or other thirds parties are those of the speaker or third party and not necessarily of LCNUK.
  • Whilst every effort has been made to ensure the information and guidance is accurate, it is impossible to predict all the circumstances in which it may be used and LCNUK assumes no responsibility or liability for any errors or omissions made in this content. All presentations are for informational and educational purposes only - content should not be considered applicable to all situations or patients.
  • The contents do not negate the requirement for comprehensive assessment, liaison and management of patients, their families and caregivers.
  • LCNUK neither endorses nor accepts responsibility for the contents of third party websites or resources included in these presentations. 
  • Sponsors have had no input into the content of LCNUK  produced presentations.  
  • LCNUK also hosts company sponsored webinars - these are clearly labelled
  • For more information see our Website Disclaimer

Speaker(s)